Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.
Capello M, Cappello P, Linty FC, Chiarle R, Sperduti I, Novarino A, Salacone P, Mandili G, Naccarati A, Sacerdote C, Beghelli S, Bersani S, Barbi S, Bassi C, Scarpa A, Nisticò P, Giovarelli M, Vineis P, Milella M, Novelli F.
Capello M, et al. Among authors: sperduti i.
J Hematol Oncol. 2013 Sep 6;6:67. doi: 10.1186/1756-8722-6-67.
J Hematol Oncol. 2013.
PMID: 24010981
Free PMC article.
Clinical Trial.